Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16811 | 570 | 36.4 | 80% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GALLIC ACID | Author keyword | 32 | 17% | 30% | 169 |
2 | TOONA SINENSIS | Author keyword | 20 | 56% | 4% | 24 |
3 | AS41 | Author keyword | 17 | 79% | 2% | 11 |
4 | CALU 6 | Author keyword | 17 | 72% | 2% | 13 |
5 | MED SCI HEALTHCARE TECHNOL DEV | Address | 15 | 73% | 2% | 11 |
6 | HEALTHCARE TECHNOL DEV MED SCI | Address | 12 | 86% | 1% | 6 |
7 | HUMAN PULMONARY FIBROBLAST | Author keyword | 9 | 83% | 1% | 5 |
8 | TOONA SINENSIS ROEM | Author keyword | 6 | 71% | 1% | 5 |
9 | PENTYL GALLATE | Author keyword | 6 | 100% | 1% | 4 |
10 | GUANGXI TRADIT CHINESE MED QUAL STAND | Address | 5 | 55% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GALLIC ACID | 32 | 17% | 30% | 169 | Search GALLIC+ACID | Search GALLIC+ACID |
2 | TOONA SINENSIS | 20 | 56% | 4% | 24 | Search TOONA+SINENSIS | Search TOONA+SINENSIS |
3 | AS41 | 17 | 79% | 2% | 11 | Search AS41 | Search AS41 |
4 | CALU 6 | 17 | 72% | 2% | 13 | Search CALU+6 | Search CALU+6 |
5 | HUMAN PULMONARY FIBROBLAST | 9 | 83% | 1% | 5 | Search HUMAN+PULMONARY+FIBROBLAST | Search HUMAN+PULMONARY+FIBROBLAST |
6 | TOONA SINENSIS ROEM | 6 | 71% | 1% | 5 | Search TOONA+SINENSIS+ROEM | Search TOONA+SINENSIS+ROEM |
7 | PENTYL GALLATE | 6 | 100% | 1% | 4 | Search PENTYL+GALLATE | Search PENTYL+GALLATE |
8 | CALF PULMONARY ARTERIAL ENDOTHELIAL CELLS | 4 | 75% | 1% | 3 | Search CALF+PULMONARY+ARTERIAL+ENDOTHELIAL+CELLS | Search CALF+PULMONARY+ARTERIAL+ENDOTHELIAL+CELLS |
9 | GALLIC ACID DERIVATIVE | 4 | 75% | 1% | 3 | Search GALLIC+ACID+DERIVATIVE | Search GALLIC+ACID+DERIVATIVE |
10 | PROPYL GALLATE | 4 | 16% | 4% | 23 | Search PROPYL+GALLATE | Search PROPYL+GALLATE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AS41 JUXTAGLOMERULAR CELLS | 27 | 76% | 3% | 19 |
2 | CALU 6 CELLS | 25 | 60% | 5% | 28 |
3 | CANCER CALU 6 CELLS | 11 | 78% | 1% | 7 |
4 | GALLIC ACID | 10 | 10% | 16% | 94 |
5 | ROEMOR | 6 | 80% | 1% | 4 |
6 | INTRACELLULAR GSH LEVEL | 6 | 100% | 1% | 4 |
7 | OCTYL GALLATE | 5 | 35% | 2% | 11 |
8 | LAURYL GALLATE | 4 | 75% | 1% | 3 |
9 | PELTIPHYLLUM PELTATUM | 3 | 100% | 1% | 3 |
10 | ANTIOXIDANT PROPYL GALLATE | 3 | 60% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Alkyl esters of gallic acid as anticancer agents: A review | 2013 | 19 | 58 | 55% |
Plant derived and dietary phenolic antioxidants: Anticancer properties | 2015 | 1 | 85 | 5% |
Gallic acid: prospects and molecular mechanisms of its anticancer activity | 2015 | 0 | 60 | 72% |
Analysis of antioxidant activity and antioxidant constituents of Chinese toon | 2009 | 14 | 18 | 28% |
Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies | 2010 | 51 | 124 | 6% |
Gallic acid and gallic acid derivatives: Effects on drug metabolizing enzymes | 2003 | 57 | 87 | 11% |
Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells | 2012 | 12 | 63 | 5% |
Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells | 2004 | 243 | 137 | 1% |
Oxyl radicals, redox-sensitive signalling cascades and antioxidants | 2007 | 178 | 189 | 1% |
Evaluation for safety of antioxidant chemopreventive agents | 2005 | 74 | 100 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED SCI HEALTHCARE TECHNOL DEV | 15 | 73% | 1.9% | 11 |
2 | HEALTHCARE TECHNOL DEV MED SCI | 12 | 86% | 1.1% | 6 |
3 | GUANGXI TRADIT CHINESE MED QUAL STAND | 5 | 55% | 1.1% | 6 |
4 | HEALTHCARE TECHNOL DEV CLIN MED | 1 | 100% | 0.4% | 2 |
5 | OSTEOPATHY WARD | 1 | 50% | 0.4% | 2 |
6 | AHVAZ PHYSIOL | 1 | 50% | 0.2% | 1 |
7 | CHINESE MED CHINESE INTERNAL MED | 1 | 50% | 0.2% | 1 |
8 | CLIN MED HEALTHCARE TECHNOL DEV | 1 | 50% | 0.2% | 1 |
9 | FSH SRC | 1 | 50% | 0.2% | 1 |
10 | GENET SCI CHRON METAB DIS | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000126892 | CEPES ESTUDOS PESQUISA PREVENCAO TRATAMENTO//NEW SOLUTION OF SIMULTANEOUS EQUATIONS//SIGNAL MULTIPLIER SPECTROPHOTOMETRY |
2 | 0.0000077709 | COTINUS COGGYGRIA//AGRIMONIA EUPATORIA//AGRIMONIA PILOSA LEDEB |
3 | 0.0000076744 | ORAL TUMOR CELLS//DENT PHARMACOL//DIAGNOST THER EUT SCI |
4 | 0.0000074158 | ENDOGENOUS COPPER//PROOXIDANT ACTION//CUII REDUCTION |
5 | 0.0000072068 | OENOTHEIN B//ELLAGITANNIN//PHARMACEUT SCI 311 MAIDASHI HIGASHI KU |
6 | 0.0000068875 | ELLAGIC ACID//LAFOENSIA PACARI//DILODENDRON BIPINNATUM |
7 | 0.0000068347 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 |
8 | 0.0000061913 | TRIPHALA//EMBLICA OFFICINALIS//TERMINALIA ARJUNA |
9 | 0.0000061824 | FERULIC ACID//ETHYL FERULATE//GLYCERYL FERULATE |
10 | 0.0000058165 | AUSTRALIAN HELICOBACTER REFERENCE//CABBAGE CULTIVATION//FUSARIUM SCIRPI |